Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Fly Intel: Top five analyst downgrades » 09:54
04/09/21
04/09
09:54
04/09/21
09:54
CS

Credit Suisse

$10.63 /

-0.32 (-2.92%)

, BTI

British American Tobacco

$38.88 /

-0.9 (-2.26%)

, CHTR

Charter

$602.06 /

-13.08 (-2.13%)

, ATUS

Altice USA

$32.73 /

-0.495 (-1.49%)

, CHUY

Chuy's

$44.60 /

-2.89 (-6.09%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Credit Suisse (CS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Magdalena Stoklosa believing "lingering uncertainty" from the hedge fund loss will delay a re-rating in the shares. 2. British American Tobacco (BTI) downgraded to Neutral from Overweight at JPMorgan with analyst Celine Pannuti saying the company is entering an investment ramp-up phase that is likely to hold back earnings growth over the medium term. 3. Charter (CHTR) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying three recent developments give the analyst pause regarding future broadband growth for cable firms: faster annual fiber upgrades, wireless home broadband ambitions, and risks from government policy direction. 4. Altice USA (ATUS) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying consensus for average broadband net adds between 2022 and 2025 "seems too robust and may need to be cut by more than half." 5. Chuy's (CHUY) downgraded to Hold from Buy at Stifel with analyst Chris O'Cull citing valuation for the downgrade following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

04/09/21 Morgan Stanley
Credit Suisse downgraded to Equal Weight from Overweight at Morgan Stanley
04/07/21 RBC Capital
Credit Suisse price target lowered to CHF 11 from CHF 14.50 at RBC Capital
04/07/21 Exane BNP Paribas
Credit Suisse downgraded to Neutral from Outperform at Exane BNP Paribas
04/06/21 JPMorgan
JPMorgan downgrades Credit Suisse to Neutral, sees shares to trade at discount
BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

04/09/21 JPMorgan
British American Tobacco downgraded to Neutral from Overweight at JPMorgan
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Jefferies
British American Tobacco upgraded to Buy from Hold at Jefferies
CHTR Charter
$602.06 /

-13.08 (-2.13%)

04/09/21 Citi
Charter downgraded to Neutral from Buy at Citi
03/16/21 Wells Fargo
Wells starts Charter at Overweight on margin expansion potential
03/16/21 Wells Fargo
Charter initiated with an Overweight at Wells Fargo
03/01/21 TD Securities
Liberty Broadband upgraded to Buy at TD Securities after Charter pullback
ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

04/09/21 Citi
Altice USA downgraded to Neutral from Buy at Citi
03/16/21 Wells Fargo
Altice USA started at Equal Weight at Wells Fargo on balanced valuation
03/16/21 Wells Fargo
Altice USA initiated with an Equal Weight at Wells Fargo
02/12/21 Pivotal Research
Altice USA earnings selloff a buying opportunity, says Pivotal Research
CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

04/09/21 Stifel
Chuy's downgraded to Hold from Buy at Stifel
03/05/21 Stephens
Chuy's price target raised to $44 from $32 at Stephens
02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

  • 13
    Aug
  • 23
    Jun
  • 06
    May
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

Downgrade
Chuy's downgraded to Hold from Buy at Stifel » 05:34
04/09/21
04/09
05:34
04/09/21
05:34
CHUY

Chuy's

$47.49 /

+0.3 (+0.64%)

Stifel analyst Chris…

Stifel analyst Chris O'Cull downgraded Chuy's to Hold from Buy with a $45 price target. The analyst cites valuation for the downgrade following the stock's recent rally. However, O'Cull remains "highly confident" in the company's near- and long-term outlook, and would consider becoming more constructive on the stock with pullbacks to the high $30 range.

ShowHide Related Items >><<
CHUY Chuy's
$47.49 /

+0.3 (+0.64%)

CHUY Chuy's
$47.49 /

+0.3 (+0.64%)

03/05/21 Stephens
Chuy's price target raised to $44 from $32 at Stephens
02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
CHUY Chuy's
$47.49 /

+0.3 (+0.64%)

Over a month ago
Recommendations
Chuy's price target raised to $44 from $32 at Stephens » 07:23
03/05/21
03/05
07:23
03/05/21
07:23
CHUY

Chuy's

$40.08 /

-1.85 (-4.41%)

Stephens analyst James…

Stephens analyst James Rutherford raised the firm's price target on Chuy's to $44 from $32 and keeps an Overweight rating on the shares following the company's quarterly report. While he notes that Chuy's comps decelerated in November and December, they didn't slow as much as he expected and there was "a good improvement in January," said Rutherford. He expects a return to pre-COVID average unit volumes, or better, by the second half of FY21, noted Rutherford.

ShowHide Related Items >><<
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

Hot Stocks
Chuy's to open four to six new restaurants in FY21  16:43
03/04/21
03/04
16:43
03/04/21
16:43
CHUY

Chuy's

$40.08 /

-1.85 (-4.41%)

 
ShowHide Related Items >><<
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

Earnings
Chuy's reports Q4 EPS 19c, consensus 14c » 16:42
03/04/21
03/04
16:42
03/04/21
16:42
CHUY

Chuy's

$40.08 /

-1.85 (-4.41%)

Reports Q4 revenue…

Reports Q4 revenue $78.7M, consensus $76.85M; Comparable restaurant sales decreased 18.3%. Comparable restaurant sales were negatively impacted by closures of dining rooms in Kentucky, Colorado and Illinois during the latter part of November and December due to the COVID-19 pandemic as well as reduced traffic during the Thanksgiving week and on Christmas Day which fell on Friday, a higher volume day, as compared to Wednesday last year. Off-premise sales remained strong at a rate more than double pre-COVID-19 levels ranging from 30% to 35% of all revenue during the fourth quarter and the first quarter of 2021 to date. As of December 27, 2020, the Company had a strong financial position with $86.8 million in cash and cash equivalents, no debt and $25.0 million of availability under its revolving credit facility. The Company believes it maintains ample financial flexibility with which to navigate the current environment.

ShowHide Related Items >><<
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
CHUY Chuy's
$40.08 /

-1.85 (-4.41%)

Downgrade
Chuy's downgraded to Market Perform from Outperform at BMO Capital » 04:56
02/25/21
02/25
04:56
02/25/21
04:56
CHUY

Chuy's

$43.99 /

+1.58 (+3.73%)

BMO Capital analyst…

BMO Capital analyst Andrew Strelzik downgraded Chuy's to Market Perform from Outperform with a price target of $42, up from $30. The analyst continues to view Chuy's long-term fundamentals favorably and expects the company to be a "prime beneficiary of reopening." However, the investment case for is "less persuasive" at current valuation levels as the risk/reward has become more balanced following recent share price outperformance, Strelzik tells investors in a research note.

ShowHide Related Items >><<
CHUY Chuy's
$43.99 /

+1.58 (+3.73%)

02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
11/16/20 BMO Capital
Chuy's upgraded to Outperform from Market Perform at BMO Capital
CHUY Chuy's
$43.99 /

+1.58 (+3.73%)

Downgrade
Chuy's downgraded to Market Perform at Raymond James on valuation » 07:28
02/10/21
02/10
07:28
02/10/21
07:28
CHUY

Chuy's

$40.48 /

-2.06 (-4.84%)

Raymond James analyst…

Raymond James analyst Brian Vaccaro downgraded Chuy's to Market Perform from Outperform following the stock's ~55% year-to-date surge that has pushed it past the firm's $40 price target and to valuation levels that are above its historical ranges. Vaccaro remains positive on the company's post- COVID fundamental outlook and strong financial position, but is moving to the sideline and would remain patient for a more attractive entry point to add to existing positions, the analyst tells investors in a research note.

ShowHide Related Items >><<
CHUY Chuy's
$40.48 /

-2.06 (-4.84%)

02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
11/16/20 BMO Capital
Chuy's upgraded to Outperform from Market Perform at BMO Capital
11/13/20 Wedbush
Chuy's price target raised to $29 from $26 at Wedbush
CHUY Chuy's
$40.48 /

-2.06 (-4.84%)

Downgrade
Chuy's downgraded to Market Perform from Outperform at Raymond James » 04:43
02/10/21
02/10
04:43
02/10/21
04:43
CHUY

Chuy's

$40.48 /

-2.06 (-4.84%)

Raymond James analyst…

Raymond James analyst Brian Vaccaro downgraded Chuy's to Market Perform from Outperform without a price target citing valuation.

ShowHide Related Items >><<
CHUY Chuy's
$40.48 /

-2.06 (-4.84%)

01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
11/16/20 BMO Capital
Chuy's upgraded to Outperform from Market Perform at BMO Capital
11/13/20 Wedbush
Chuy's price target raised to $29 from $26 at Wedbush
11/06/20 BMO Capital
Chuy's price target raised to $25 from $20 at BMO Capital
CHUY Chuy's
$40.48 /

-2.06 (-4.84%)

Upgrade
Chuy's upgraded to Buy from Hold at Stifel » 06:45
01/15/21
01/15
06:45
01/15/21
06:45
CHUY

Chuy's

$30.34 /

+0.52 (+1.74%)

Stifel analyst Chris…

Stifel analyst Chris O'Cull upgraded Chuy's to Buy from Hold with a price target of $40, up from $23, citing expected unit growth and its likely benefit from higher-income consumers' pent-up demand. He projects Chuy's net unit expansion rate will climb to 10% in 2023 and that its commitment to backfill existing markets should lead to better new unit performance and "a higher hit rate of success," O'Cull tells investors.

ShowHide Related Items >><<
CHUY Chuy's
$30.34 /

+0.52 (+1.74%)

11/16/20 BMO Capital
Chuy's upgraded to Outperform from Market Perform at BMO Capital
11/13/20 Wedbush
Chuy's price target raised to $29 from $26 at Wedbush
11/06/20 BMO Capital
Chuy's price target raised to $25 from $20 at BMO Capital
08/07/20 Stephens
Chuy's price target raised to $21 from $20 at Stephens
CHUY Chuy's
$30.34 /

+0.52 (+1.74%)

Over a quarter ago
Upgrade
Chuy's upgraded to Outperform from Market Perform at BMO Capital » 05:07
11/16/20
11/16
05:07
11/16/20
05:07
CHUY

Chuy's

$22.62 /

+0.43 (+1.94%)

BMO Capital analyst…

BMO Capital analyst Andrew Strelzik upgraded Chuy's to Outperform from Market Perform with a price target of $30, up from $25. Last week's positive vaccine news allows investors to look out beyond near-term volatility to theoretical 2022 EBITDA, Strelzik tells investors in a research note. The analyst believes Chuy's has the potential to emerge from the pandemic with stronger unit volumes and a transformed margin structure which should lead to accelerated unit growth.

ShowHide Related Items >><<
CHUY Chuy's
$22.62 /

+0.43 (+1.94%)

CHUY Chuy's
$22.62 /

+0.43 (+1.94%)

11/13/20 Wedbush
Chuy's price target raised to $29 from $26 at Wedbush
11/06/20 BMO Capital
Chuy's price target raised to $25 from $20 at BMO Capital
08/07/20 Stephens
Chuy's price target raised to $21 from $20 at Stephens
05/29/20 Jefferies
Bloomin' Brands upgraded to Buy on early read on reopenings at Jefferies
CHUY Chuy's
$22.62 /

+0.43 (+1.94%)

CHUY Chuy's
$22.62 /

+0.43 (+1.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.